Scientists investigate gut-healing protein in Crohn's and colitis
NCT ID NCT02847052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a protein called IL-22 binding protein (IL-22BP) affects gut healing in people with Crohn's disease or ulcerative colitis. Researchers compared samples from 52 patients and healthy volunteers to understand how IL-22BP is regulated during disease flares. The goal was to learn more about the disease process, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study clarifies how IL-22BP controls gut repair, it could point toward new drug targets for inflammatory bowel disease.
- What could go wrong
- This was a small, observational study that did not test any treatment. The findings may not lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nantes
Nantes, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves vs. scope: a gentler way to spot pouch inflammation?
- Can a patient registry unlock the secrets of IBD?
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can we predict how kids with IBD will respond to treatment?
- Could IBD medications during pregnancy shape a Child's development?
- Can AI learn to grade endoscopy quality from video?